Longeveron (LGVN)
Develops donor-derived cell therapy for pediatric cardiac and aging-related diseases.
$2.69
After hours−0.03 (−1.08%)
At close$2.72(+11.02%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 14.94% | 476.3K shares | |
|---|---|---|---|
| 39 holders · as of Jun 30, 2026 | |||
| Insiders | 7.29% | 232.3K shares | |
| 12 holders · as of Aug 25, 2026 | |||
| Other | 77.77% | 2.48M shares | |
| remainder | |||
3.19M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
This company has 2 share classes; every stake here is a share of the whole company.
13F, as of Jun 30, 2026
39 holders · 4.76M shares · 14 new positions · 21 increased · 3 reduced · 5 closed
| Holder | Shares | % of company | Chg q/q | Filed |
|---|---|---|---|---|
| Millennium Management LLC | 1.35M | 42.47% | +907.2K | Aug 14, 2026 |
| Logos Global Management LP | 1.29M | 40.37% | +1.29Mnew | Aug 14, 2026 |
| Vanguard Capital Management LLC | 581.3K | 18.23% | +39.3K | Aug 13, 2026 |
| BlackRock, Inc. | 224.2K | 7.03% | −28 | Aug 7, 2026 |
| Geode Capital Management, LLC | 203.8K | 6.39% | +143 | Aug 12, 2026 |
| Jane Street Group, LLC | 190.4K | 5.97% | +4.7K | Aug 14, 2026 |
| Vanguard Fiduciary Trust Co | 140.1K | 4.40% | +101.4K | Aug 13, 2026 |
| Mariner, LLC | 126.0K | 3.95% | +126.0Knew | Aug 13, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Mitchell P. Kopin | 9.99% | 13G | Aug 15, 2025 | |
| Logos Global Management LP | 6.30% | 192.3K | 13G | Sep 10, 2026 |
| Janus Henderson Group PLC | 5.90% | 13G | May 15, 2026 | |
| Integrated Core Strategies (US) LLC | 5.20% | 13G | Aug 10, 2026 |
Form 4
Latest trades
No open-market trades in the last 12 months.
House and Senate disclosures
Not reported.